Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determination of the 9Be( alpha,n)12C reaction rate.
Kunz R, Barth S, Denker A, Drotleff HW, Hammer JW, Knee H, Mayer A. Kunz R, et al. Among authors: denker a. Phys Rev C Nucl Phys. 1996 May;53(5):2486-2495. doi: 10.1103/physrevc.53.2486. Phys Rev C Nucl Phys. 1996. PMID: 9971229 No abstract available.
Alpha scattering and capture reactions in the A=7 system at low energies.
Mohr P, Abele H, Zwiebel R, Staudt G, Krauss H, Oberhummer H, Denker A, Hammer JW, Wolf G. Mohr P, et al. Among authors: denker a. Phys Rev C Nucl Phys. 1993 Sep;48(3):1420-1427. doi: 10.1103/physrevc.48.1420. Phys Rev C Nucl Phys. 1993. PMID: 9968972 No abstract available.
PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy.
Hrbacek J, Kacperek A, Beenakker JM, Mortimer L, Denker A, Mazal A, Shih HA, Dendale R, Slopsema R, Heufelder J, Mishra KK. Hrbacek J, et al. Among authors: denker a. Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00748-X. doi: 10.1016/j.ijrobp.2024.06.017. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38971383 Free article. Review.
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CCS, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M. Krakow EF, et al. Among authors: denker ae. Blood. 2024 Sep 5;144(10):1069-1082. doi: 10.1182/blood.2024024105. Blood. 2024. PMID: 38683966 Clinical Trial.
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: denker ae. Kidney Int. 2023 Jul;104(1):205. doi: 10.1016/j.kint.2023.04.010. Kidney Int. 2023. PMID: 37349053 Free article. No abstract available.
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies.
Pisani L, Algera AG, Neto AS, Azevedo L, Pham T, Paulus F, de Abreu MG, Pelosi P, Dondorp AM, Bellani G, Laffey JG, Schultz MJ; ERICC study investigators; LUNG SAFE study investigators; PRoVENT study investigators; PRoVENT-iMiC study investigators. Pisani L, et al. Lancet Glob Health. 2022 Feb;10(2):e227-e235. doi: 10.1016/S2214-109X(21)00485-X. Epub 2021 Dec 13. Lancet Glob Health. 2022. PMID: 34914899 Free PMC article.
71 results